1. Home
  2. CHEK vs ONCO Comparison

CHEK vs ONCO Comparison

Compare CHEK & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • ONCO
  • Stock Information
  • Founded
  • CHEK 2004
  • ONCO 2018
  • Country
  • CHEK Israel
  • ONCO United States
  • Employees
  • CHEK N/A
  • ONCO N/A
  • Industry
  • CHEK Medical Electronics
  • ONCO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • ONCO Health Care
  • Exchange
  • CHEK Nasdaq
  • ONCO Nasdaq
  • Market Cap
  • CHEK 9.0M
  • ONCO 9.4M
  • IPO Year
  • CHEK 2015
  • ONCO 2022
  • Fundamental
  • Price
  • CHEK $0.86
  • ONCO $0.54
  • Analyst Decision
  • CHEK
  • ONCO
  • Analyst Count
  • CHEK 0
  • ONCO 0
  • Target Price
  • CHEK N/A
  • ONCO N/A
  • AVG Volume (30 Days)
  • CHEK 70.6K
  • ONCO 9.9M
  • Earning Date
  • CHEK 02-25-2025
  • ONCO 04-10-2025
  • Dividend Yield
  • CHEK N/A
  • ONCO N/A
  • EPS Growth
  • CHEK N/A
  • ONCO N/A
  • EPS
  • CHEK N/A
  • ONCO N/A
  • Revenue
  • CHEK N/A
  • ONCO $1,870,605.00
  • Revenue This Year
  • CHEK N/A
  • ONCO N/A
  • Revenue Next Year
  • CHEK N/A
  • ONCO N/A
  • P/E Ratio
  • CHEK N/A
  • ONCO N/A
  • Revenue Growth
  • CHEK N/A
  • ONCO N/A
  • 52 Week Low
  • CHEK $0.56
  • ONCO $0.32
  • 52 Week High
  • CHEK $3.45
  • ONCO $21.40
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 41.78
  • ONCO 43.36
  • Support Level
  • CHEK $0.81
  • ONCO $0.53
  • Resistance Level
  • CHEK $0.97
  • ONCO $0.70
  • Average True Range (ATR)
  • CHEK 0.10
  • ONCO 0.06
  • MACD
  • CHEK -0.02
  • ONCO 0.00
  • Stochastic Oscillator
  • CHEK 13.42
  • ONCO 15.40

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: